AstraZeneca's Tagrisso slashes death risk in certain post-surgery lung cancer patients - Reuters
- AstraZeneca's Tagrisso slashes death risk in certain post-surgery lung cancer patients Reuters
- Lung cancer pill cuts risk of death by half, says ‘thrilling’ study The Guardian
- Stopping treatment at two years does not seem to compromise overall survival in patients with advanced lung cancer News-Medical.Net
- Game-Changer: Tagrisso May Reduce Risk of Death by Half in Some Early-Stage Lung Cancer Patients, 'Compelling' New Data Shows SurvivorNet
- 'Extraordinary' survival data for lung cancer patients is seen as boost for AstraZeneca drug STAT
- View Full Coverage on Google News